News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|March 3, 2017

Navigating a Colon Cancer Journey

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
The FDA granted fast track status to muzastotug plus Keytruda for adults with microsatellite stable metastatic colorectal cancer without liver metastases: © stock.adobe.com.

FDA Grants Fast Track Status to Muzastotug for Some Colorectal Cancers

BySpencer Feldman
December 16th 2025
Image of two people.

Experts Highlight Notable Advances in Colorectal Cancer at 2025 ESMO

ByDr. Joshua K. Sabari
November 13th 2025
Image of hands.

I’m Still Here: My Fight Against Colorectal Cancer

ByChrista Messmer
October 28th 2025
The FDA grants fast track status to alnodesertib in mCRC with ATM deficiency: © stock.adobe.com.

Alnodesertib Wins FDA Fast Track Status in ATM-Negative Colorectal Cancer

BySpencer Feldman
September 24th 2025
Image of colorectal cancer

A Patient's Guide to Understanding Colorectal Cancer

BySpencer Feldman
September 5th 2025
Advertisement
Advertisement

Trending on CURE

1

Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC

2

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

3

Stage 4 Pancreatic Cancer Survivor Shares Clinical Trial Path

4

New Approach May Offer Stronger Treatment Effects in Metastatic Breast Cancer

5

Navigating the Holidays When Cancer Never Quite Leaves

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.